We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SEER:NASDAQSeer, Inc. Analysis

Data as of 2026-05-26 - not real-time

$1.85

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Seer, Inc. is trading just above its short‑term moving averages while remaining below its long‑term trend line, suggesting limited near‑term upside. The price sits in a neutral RSI zone and the MACD has turned bearish, with declining volume adding pressure to the short‑term outlook. Fundamentally, the company posted a sharp revenue decline and operates at a loss, yet it retains a sizable cash buffer that far exceeds its modest market capitalization, providing runway for continued R&D and commercial rollout. Recent material news highlights reaffirmed full‑year revenue guidance, new commercial leadership hires, and a defensive stance against an unsolicited acquisition proposal, underscoring management confidence despite the challenging quarter. The sector’s high inherent risk, coupled with elevated volatility and a neutral market sentiment index, tempers enthusiasm, but the low price‑to‑book multiple and analyst’s strong‑buy rating point to a potentially undervalued position with significant upside potential.
Investors should weigh the company’s cash strength and growth narrative against its negative margins, bearish technical signals, and sector‑specific regulatory uncertainties. The current environment favors a cautious stance, leaning toward a medium‑term accumulation thesis while remaining vigilant of short‑term price pressure and liquidity constraints.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price below long‑term average
  • bearish MACD momentum
  • declining volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • substantial cash cushion
  • analyst strong‑buy rating
  • potential upside indicated by low price‑to‑book

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • high sector volatility
  • ongoing revenue decline
  • strategic commercial leadership hires

Key Metrics & Analysis

Financial Health

Revenue Growth-33.60%
P/E Ratio-1.9
ROE-25.52%
ROA-15.04%
Debt/Equity9.54
P/B Ratio0.4
Industry P/E27.5

Technical Analysis

TrendNeutral
RSI53.0
Support$1.67
Resistance$2.09
MA 20$1.83
MA 50$1.81
MA 200$1.96
MACDBearish
VolumeDecreasing
Fear & Greed Index90.95

Valuation

Target Price$4.00
Upside/Downside116.80%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.91
Volatility38.90%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.